Skip to main content

PEPTIDE DOSSIER · PRACTICAL TOOLS

What changed

Substantive tool and reference updates, with the usable destination and its scope.

Subscribe to public RSS

No account or email address is required. Add the feed URL to the reader of your choice; journal and reading-list data never enter the feed.

NOVEMBER 12, 2026 · TOOL SUITE V1

Practical tools, private records and source-linked references

The tools hub connects a conversion workbench, manual cost comparison, meal allocation, private journal with site history and export, printable kit, synthetic COA guide, two-presentation storage lookup, primary-trial explorer, selected FDA history, evidence matrix and saved reading brief.

New ecnoglutide and cotadutide notes distinguish study populations and questions. The existing eloralintide guide remains its canonical destination.

The journal saves only by explicit choice. Optional generic tool measurement is separate and off by default. Read the data boundary, walkthroughs and shareable resources.

Scope and version notes

Manual costs use actual billing dates and do not contain vendor quotes. Meal allocation starts from a user-chosen target. The persistence chart is conceptual, not a personalized model. Trial and approval collections are selected references, not comprehensive live databases. Current source-check dates appear with the records.

NOVEMBER 11, 2026 · EVIDENCE NOTE

Eloralintide primary evidence guide

The existing guide separates monotherapy evidence from combination research and registrations from results. Its bibliography and source-check scope are retained.

Corrections and methodology: editorial policy.